As a trusted pharmaceutical manufacturer with an EU-GMP certified factory, Ampharco U.S.A was honored to sponsor the Cho Ray Hospital Annual Scientific Conference 2026 on April 16, 2026. The conference brought together more than 1,000 doctors, pharmacists and healthcare professionals from across Vietnam.
Through this event, Ampharco U.S.A continued to show its commitment to supporting the medical community, sharing medical knowledge and improving healthcare for patients.Đồng hành cùng diễn đàn khoa học uy tín của ngành y tế Việt Nam
Supporting a Leading Scientific Conference
Cho Ray Hospital is a Special-Class General Hospital under the Ministry of Health and the leading specialized hospital in Southern Vietnam. The hospital plays an important role in medical treatment, training and scientific research.
The Cho Ray Hospital Annual Scientific Conference 2026 welcomed doctors, pharmacists and healthcare professionals from many hospitals and medical institutions across the country. The conference included nearly 420 scientific presentations in many medical fields, together with the participation of international experts. The event provided an important opportunity for healthcare professionals to update new medical knowledge, exchange work experience and discuss new developments in medical treatment.
Ampharco U.S.A Connects with the Medical Community
As one of the conference sponsors, Ampharco U.S.A was proud to support this important scientific event and continuous medical education activities for healthcare professionals.
During the conference, representatives of Ampharco U.S.A had the opportunity to meet and exchange ideas with doctors, pharmacists and medical experts. It was also a valuable chance for the company to better understand the real needs of clinical practice and continue developing healthcare solutions that meet the growing needs of patients.
Taking part in scientific conferences has become one of Ampharco U.S.A's regular activities to strengthen its connection with the medical community while supporting knowledge sharing and professional development.
Commitment to Quality with an EU-GMP Certified Factory
Besides supporting scientific and educational activities, Ampharco U.S.A continues to invest in research, product development and manufacturing to provide high-quality pharmaceutical products.
In 2025, Ampharco U.S.A's factory officially received EU-GMP certification, one of the highest international standards for pharmaceutical manufacturing. This achievement is a strong proof of the company's commitment to product quality, modern manufacturing and international quality management.
By joining scientific conferences like this, Ampharco U.S.A continues to support the development of Vietnam's healthcare sector while staying committed to quality, science and better healthcare for patients.